Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer; Metastatic Non-Small Cell Lung Cancer; NSCLC; KRAS G12C; Metastatic Lung Cancer; Advanced Lung Carcinoma Interventions: Drug: BBO-8520; Drug: Pembrolizumab Sponsors: TheRas, Inc Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Lung Cancer | Non-Small Cell Lung Cancer | Research | Study